May, 2020

article thumbnail

Fuld + Company’s COVID-19 Impact Survey

Fuld

Fuld + Company is surveying how the work of Strategy, Competitive Intelligence and Market Insights functions is changing as companies respond to the global pandemic. Companies around the world are adjusting to the unprecedented operational and financial impact of the COVID-19 pandemic. With this short survey , Fuld + Company aims to better understand what has changed for specific strategy- and intelligence-focused functions and how they are supporting the response, re-positioning, and decision-m

52
article thumbnail

Looking Beyond Prescription Medications with Integrative Medicine

The Nontraditional Pharmacist

Pharmacists practicing integrative medicine do not transition from the role of the pharmacist but rather expand it. Dr. Pam Tarlow and Dr. Swathi Varanasi highlight the importance of other modalities of health and even touch on the business implications of integrative medicine in the future! Dr. Pam Tarlow and Dr. Swathi Varanasi – Clinical, Integrative Pharmacists.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

REVIEW ON COVID -19(CORONA VIRUS DISEASE)

Pharma Tutor

AUTHORS : * Tinku Kumar Singh 1 , Satish Kumar 1 , Purna Tiwari 2 1 Indchemie health Specialities Pvt. Ltd 2 Alkem health science Ltd. tinku20190@gmail.com. . ABSTRACT : The World Health Organization (WHO) has declared the corona virus disease 2019 (COVID-19) a pandemic. In January 2020, a previously unknown new virus was identified subsequently named the 2019 novel corona virus, and samples obtained from cases and analysis of the virus’ genetics indicated that this was the cause of the outbrea

48
article thumbnail

QT Prolongation for Community Pharmacists: Quick Guide

Med Ed 101

I’m extremely grateful for the many pharmacists who have stepped up and provided education on topics they are passionate about. I’ve touched on QT prolongation in the past, but Daniel Lieu, PharmD has taken it up a notch! He has provided some spot-on education below on QT Prolongation for Community Pharmacists that can be applied […].

40
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

COVID-19 May Briefing: The UK&I Healthcare Ecosystem Fightback

pharmaphorum

Insights on the impact of COVID-19 for pharma and biotech companies and considerations for a post-coronavirus new normal in life sciences and healthcare. It will also discuss the UK response to the emergency, clinical trials and how digital health has met the COVID-19 challenge for healthcare professionals, patients and industry.

40
article thumbnail

Digoxin in CHF – What You Need to Know

Med Ed 101

Digoxin is one of those medications that has a lot of unique clinical quirks. Here are a few clinical pearls you must remember when using digoxin in CHF. When using digoxin in CHF (more specifically (HFrEF) you must remember to check electrolytes. Alterations in electrolytes may increase the risk of arrhythmias. When a patient has […]. The post Digoxin in CHF – What You Need to Know appeared first on Med Ed 101.

40

More Trending

article thumbnail

Nuedexta Off-Label Fraud

Med Ed 101

I stumbled into this article a while ago regarding Nuedexta off-label fraud for behavioral issues involving dementia patients in long term care facilities. It makes me sad and frustrated. I’d like to make a couple of points. Nuedexta Off-Label Evidence in Dementia The evidence of Nuedexta being beneficial in this patient population for the off-label […].

article thumbnail

MINI REVIEW OF SCOTT CRANIODIGITAL SYNDROME

Pharma Tutor

AUTHORS : Gouranga Sundar Roy 1 *, Sangita Biswas 2 . Department of Pharmacy, Bengal School of Technology. (A College of Pharmacy), Sugandha, Delhi Road Near Chuchura, Hooghly - 712102, West Bengal, India. ABSTRACT: Scott Craniodigital syndrome is a situation that has best been found in families. The manifestations consist of uncommon head shape, boom and developmental delay, and mild webbing between the arms and toes.

40
article thumbnail

These Things Make Me Think Twice in Geriatrics

Med Ed 101

Geriatrics can get very complicated very fast. Chronic conditions, polypharmacy, and drug interactions are a few of the many complications. Here are a few things that make me think twice in geriatric patients. Multiple Medication Changes As I reveiw a patient’s medication list, I review recent changes that have been made. The more changes that […].

40
article thumbnail

Ciprofloxacin for Pneumonia?

Med Ed 101

I do get quite a few questions from time to time and try to answer as many emails as I can. Here were a few really good questions that I thought I would share with all of you. Can we use ciprofloxacin for pneumonia? Why isn’t ciprofloxacin a treatment in community-acquired pneumonia? Also, why is […]. The post Ciprofloxacin for Pneumonia?

40
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Monitoring Loop Diuretics; What Do I Think About?

Med Ed 101

Loop diuretics are the mainstay in removing fluid off the body in patients with heart failure. They are very common in clinical practice. What should you think about when monitoring loop diuretics? Monitoring Loop Diuretics – Benefit? One of the challenges with polypharmacy in our geriatric patient population is to continually assess the benefit of […].

40
article thumbnail

Mirabegron Clinical Pearls

Med Ed 101

Mirabegron is a medication that can be used for overactive bladder. It is a medication that I am seeing used periodically in clinical practice. Here are a few mirabegron clinical pearls that I think are valuable to remember. The mechanism of action is critical to remember. It is a selective beta-3 agonist. You are likely […]. The post Mirabegron Clinical Pearls appeared first on Med Ed 101.

40
article thumbnail

NURSES’ PERCEPTION OF MOTIVATION AND JOB SATISFACTION IN GHANA: A CASE STUDY OF THE KORLE-BU TEACHING HOSPITAL IN ACCRA

Pharma Tutor

AUTHORS : 1 Charles Owusu-Aduomi Botchwey * , 2 Yaa Kusi-Ameyaa, 1 Isaac Adom-Konadu, 1 Ebenezer Dzinpa Effisah 1 University of Cape Coast 2 University of Professional Studies-Accra. chaboat08@yahoo.com *. ABSTRACT. Healthcare provision aims at ensuring that clients who visit a healthcare facility are provided with affordable and quality healthcare aimed at promoting the well-being of the people in the catchment areas of the healthcare facility.

article thumbnail

What Does it Take to Create a Transitional Care Model

Med Ed 101

Transitions of care are a big deal and something I care about deeply. I’ve seen so many mistakes in my practice as an MTM pharmacist, Assisted Living Consultant, LTC Consultant, and in community pharmacy. I recently watched some of Blair Thielemeir’s Elevate Pharmacy Summit and I was really inspired by the effort and energy this […].

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.